A leading pharmaceutical organization’s commercial team was purposed with acquiring multi-touchpoint feedback around the subject cardiovascular cancer. Specifically, the team needed to engage 3 sets of clinical experts – thoracic oncologists, thoracic nurses, and clinical pharmacists. In tandem with face-to-face meetings, the team needed an alternative meeting option that would prove both cost- effective and logistically friendly.
This additional clinical engagement opportunity would need to facilitate discussions tailored to each groups’ unique roles and perspectives around specific treatment options, patient interactive perspectives, and required materials for optimal patient education.
This case study examines how they took an innovative approach to achieving necessary clinical engagement outcomes.
Conducting simultaneous multi-clinician stakeholder advisory boards consisting of 20 experts located around the country – without requiring any travel or scheduling efforts and related expenses – resulted in significant cost savings, and full, convenient participation.Commercial Lead Moderator